Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LADIGAGA: Tecfidera for Geographic Atrophy
NCT04292080Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2022
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dimethyl fumarate in geographic atrophy (GA), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2022; status: recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT04292080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04292080.